Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs. CML ...
Novartis’ Scemblix continued to show superior efficacy and favourable safety and tolerability profile at week 144 in newly diagnosed CML: Basel Wednesday, June 3, 2026, 13:00 Hr ...
The immediate goal of Chronic Myeloid Leukemia (CML) therapy, operational cure, is defined as survival like sex- age-adjusted normals and a normal quality-of-life (QoL). This is being met in many ...
Tyrosine kinase inhibitors (TKIs) have transformed the treatment of chronic myeloid leukemia (CML). In a study involving patients with CML in high-income countries, approximately half the patients who ...
Growing improvement in major molecular response (MMR) rates demonstrated with Scemblix vs. all standard-of-careTKIs including imatinib and second generation (2G) TKIs1Clinically relevant 15.2% higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results